Pro Medicus Locks in A$16M Renewal as Ohio State Expands Its Imaging Platform
Pro Medicus locks in A$16M renewal with Ohio State University Wexner Medical Center
Pro Medicus Limited (ASX: PME), via its wholly-owned U.S. subsidiary Visage Imaging, Inc., has signed a 5-year, A$16M contract renewal with The Ohio State University Wexner Medical Center (OSUWMC). The renewal expands the existing relationship to include Visage 7 Workflow and Visage 7 Cardiology Imaging alongside current services.
The deal is a renewal, not a new client win, making it a signal of platform stickiness rather than top-of-funnel growth. It also demonstrates that existing clients are consolidating further onto the Visage 7 Enterprise Imaging Platform rather than seeking alternatives.
OSUWMC is a large multidisciplinary academic medical centre in Columbus, Ohio, employing approximately 22,000 staff and 2,000 physicians, supporting over 1,400 inpatient beds across six hospitals. It also serves as the teaching hospital for The Ohio State University College of Medicine.
When big ASX news breaks, our subscribers know first
What the renewal signals about Pro Medicus’ platform strategy
From radiology to enterprise imaging — expanding the Visage 7 footprint
The addition of Visage 7 Workflow and Visage 7 Cardiology Imaging to an existing client relationship is evidence of organic expansion within the installed base. Rather than acquiring new logos, Pro Medicus is deepening its footprint at institutions already running Visage 7, as those clients retire legacy solutions and broaden their deployments.
Dr Sam Hupert, Chief Executive Officer of Pro Medicus, framed the development in these terms:
Dr Sam Hupert, CEO, Pro Medicus
“Renewing this contract, to now include the additions of Visage 7 Workflow and Visage 7 Cardiology Imaging, confirms our belief that we have extensive native capabilities that Visage customers appreciate as they seek to retire legacy solutions and continue to scale their Visage 7 Enterprise Imaging Platform.”
Understanding Pro Medicus’ transaction-based model
Pro Medicus operates on a transaction-based revenue model, meaning the company earns revenue for each imaging study processed through its platform, rather than charging a flat annual licence fee. For investors, this structure is notable because it combines revenue certainty with volume upside.
This renewal was negotiated with both increased minimums and an increased fee per transaction, directly improving the revenue quality of the contract.
- Revenue earned per imaging transaction processed
- Contracted minimums provide baseline revenue certainty
- Volume above minimums generates incremental upside
- Increased fee per transaction in this renewal improves unit economics
A$141M in renewals — the retention story underpinning PME’s investment case
Renewals as a financial year milestone
The OSUWMC contract brings Pro Medicus’ total renewals for the financial year to A$141M. That figure spans the company’s broader client base and reflects a consistent pattern of clients re-committing to the platform at contract expiry.
Dr Sam Hupert, CEO, Pro Medicus
“This contract brings our total renewals for the financial year to A$141M, maintaining our track record of client retention. This underpins our belief that our solution provides unparalleled return on investment from both a financial and a clinical perspective.”
Why retention metrics matter for PME investors
A high-retention, transaction-based model at this scale carries specific implications for how investors assess revenue quality and durability.
- Renewals de-risk revenue — contracted minimums provide multi-year revenue visibility, reducing reliance on new sales to sustain earnings.
- Expansion within renewals signals platform depth — the addition of new modules at contract renewal indicates growing wallet share per client, not just maintenance of existing revenue.
- A$141M in FY renewals confirms mission-critical status — at this scale, the data suggests enterprise imaging clients treat the Visage 7 Enterprise Imaging Platform as a deeply embedded, operationally critical system.
| Contract Detail | Specifics |
|---|---|
| Client | The Ohio State University Wexner Medical Center (OSUWMC) |
| Contract Value | A$16M |
| Term | 5 years |
| New Additions | Visage 7 Workflow, Visage 7 Cardiology Imaging |
| Revenue Model | Transaction-based, increased minimums and increased fee per transaction |
The next major ASX story will hit our subscribers first
What’s next for Pro Medicus
Pro Medicus remains focused on scaling the Visage 7 Enterprise Imaging Platform across its global client base, with offices in Melbourne, Berlin, and San Diego. The company’s offering spans RIS, PACS, artificial intelligence, and e-health solutions, deployable across both public and private cloud environments.
With A$141M in renewals secured for the financial year, the near-term focus centres on sustaining that retention track record while continuing to expand module adoption within existing enterprise relationships.
Don’t Miss the Next Healthcare Sector Mover
Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ investors who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button at StockWire X to start receiving alerts today.